red blood cells

Project ECHO: Recognition and Care of Women with Bleeding Disorders

Session 2: Testing for Bleeding Disorders in OB/GYN Care

Our second webinar in a four-part series for OB/GYNs will look at the common labs ordered for patients with Heavy Menstrual Bleeding (HMB) and how to interpret the results. What additional testing can be done if the index of suspicion continues to be raised by the preliminary results? While this presentation is open to the public, the content is intended for OB/GYNs and will provide one CME credit for physicians, PAs, and nurses.

Host/Moderator: Patricia Huguelet, MD
Presenter: Maureen Baldwin, MD
Target Audience: OB/GYN

Session Objectives

  1. Identify resources to screen and monitor gynecologic and obstetric bleeding symptoms. 
  2. Identify the standard laboratory evaluation to test for bleeding disorders. 
  3. Identify pitfalls of testing and referral considerations. 
  4. Recognize next steps in care if a bleeding disorder is suspected.
TimePresentationPresenters
12:00–12:02 PM ETWelcome, Introductions, and HousekeepingPatricia Huguelet, MD
12:02–12:22 PM ETDidactic Presentation: Testing for Bleeding Disorders in OB/GYN CareMaureen Baldwin, MD
12:22–12:27 PM ETQuestion and AnswerMaureen Baldwin, MD
12:27–12:42 PM ETCase PresentationPatricia Huguelet, MD
12:42–12:47 PM ETClarifying QuestionsPatricia Huguelet, MD
12:47–12:57 PM ETRecommendationsMaureen Baldwin, MD
12:57–12:59 PM ETWrap-UpPatricia Huguelet, MD
12:59–1:00 PM ETClosing RemarksPatricia Huguelet, MD

Reminders

PHIAll patient information will be de-identified during the ECHO session.
RecordingThis session may be audio and video recorded. Your participation confirms your consent to this recording.
Continuing Medical Education Credit1 Hour

In support of improving patient care, this activity has been planned and implemented by the Hemophilia Federation of America and Project ECHO. Project ECHO is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA Designation Statement

Project ECHO® designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ANCC Designation Statement

Project ECHO designates this live activity for a maximum of 1.0 ANCC contact hours. Nursing contact hours will be awarded for successful completion of program components based upon documented attendance and completion of evaluation.

AAPA Credit Designation Statement—Live

Project ECHO has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. 

Disclosure Statement

Project ECHO®, in compliance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, requires that anyone who is in a position to control the content of an educational activity disclose all relevant financial relationships they have had within the last 24 months with an ineligible company.  

None of the planners and presenters for this educational activity have a relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

Planners: Jacey Gonzalez, BA; Skye Peltier, MPH, PA-C; Janet Chupka, RN, BSN; and Emily Roush-Bobolz, BA

The following planners/presenters listed below have disclosed that they have a relevant financial relationship with an ineligible company.

NameNature of RelationshipName of Ineligible Company
Patricia Huguelet, MDSpeaker
Speaker
Bayer Pharmaceuticals Hemophilia Federation of America
Stormy JohnsonSpeaker Music projectMedexus Pharmaceutical Sanofi
Kristina Haley, DO, MCRConsultant ResearcherRegence/Cambia Spark Therapeutics
Maureen Baldwin, DOConsultant and AdvisorBioMarin Pharmaceuticals

All of the relevant financial relationships listed for these individuals have been mitigated. 

This project is supported by cooperative agreement DD000008 from the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of an annual financial assistance award totaling $320,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

Date
Sep 09 2024
Expired!
Time
12:00 pm - 1:00 pm
More Info
Register
Category
QR Code
en_USEnglish